Induction of robust cellular immunity against HPV6 and HPV11 in mice by DNA vaccine encoding for E6/E7 antigen

References

• WHO/ICO HPV Information Centre. Human Papillomavirus and Related Cancers in World. Summary Report 2010. WHO. [ www. who. int/hpvcentre] Accessed on 8 July 2011.
   Google Scholar
• Muñoz N, Bosch FX, Castellsagué X, Díaz M, de Sanjose S, Hammouda D, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004; 111:278 - 85; http://dx.doi.org/10.1002/ijc.20244; PMID: 15197783
   PubMed Web of Science ®Google Scholar
• Lin HW, Richmon JD, Emerick KS, de Venecia RK, Zeitels SM, Faquin WC, et al. Malignant transformation of a highly aggressive human papillomavirus type 11-associated recurrent respiratory papillomatosis. Am J Otolaryngol 2010; 31:291 - 6; http://dx.doi.org/10.1016/j.amjoto.2009.02.019; PMID: 20015762
   PubMed Web of Science ®Google Scholar
• Bonagura VR, Hatam LJ, Rosenthal DW, de Voti JA, Lam F, Steinberg BM, et al. Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11. APMIS 2010; 118:455 - 70; http://dx.doi.org/10.1111/j.1600-0463.2010.02617.x; PMID: 20553528
   PubMed Web of Science ®Google Scholar
• Donne AJ, Hampson L, Homer JJ, Hampson IN. The role of HPV type in Recurrent Respiratory Papillomatosis. Int J Pediatr Otorhinolaryngol 2010; 74:7 - 14; http://dx.doi.org/10.1016/j.ijporl.2009.09.004; PMID: 19800138
   PubMed Web of Science ®Google Scholar
• Combita AL, Touzé A, Bousarghin L, Christensen ND, Coursaget P. Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses. J Virol 2002; 76:6480 - 6; http://dx.doi.org/10.1128/JVI.76.13.6480-6486.2002; PMID: 12050360
   PubMed Web of Science ®Google Scholar
• Hildesheim A, Herrero R, Wacholder S, Rodriguez AC, Solomon D, Bratti MC, et al, Costa Rican HPV Vaccine Trial Group. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA 2007; 298:743 - 53; http://dx.doi.org/10.1001/jama.298.7.743; PMID: 17699008
   PubMed Web of Science ®Google Scholar
• Lin K, Roosinovich E, Ma B, Hung CF, Wu TC. Therapeutic HPV DNA vaccines. Immunol Res 2010; 47:86 - 112; http://dx.doi.org/10.1007/s12026-009-8141-6; PMID: 20066511
   PubMed Web of Science ®Google Scholar
• Gissmann L. HPV vaccines: preclinical development. Arch Med Res 2009; 40:466 - 70; http://dx.doi.org/10.1016/j.arcmed.2009.07.002; PMID: 19853186
   PubMed Web of Science ®Google Scholar
• Kanodia S, Da Silva DM, Kast WM. Recent advances in strategies for immunotherapy of human papillomavirus-induced lesions. Int J Cancer 2008; 122:247 - 59; http://dx.doi.org/10.1002/ijc.23252; PMID: 17973257
   PubMed Web of Science ®Google Scholar
• Santin AD, Bellone S, Palmieri M, Zanolini A, Ravaggi A, Siegel ER, et al. Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial. J Virol 2008; 82:1968 - 79; http://dx.doi.org/10.1128/JVI.02343-07; PMID: 18057249
   PubMed Web of Science ®Google Scholar
• Yan J, Harris K, Khan AS, Draghia-Akli R, Sewell D, Weiner DB. Cellular immunity induced by a novel HPV18 DNA vaccine encoding an E6/E7 fusion consensus protein in mice and rhesus macaques. Vaccine 2008; 26:5210 - 5; http://dx.doi.org/10.1016/j.vaccine.2008.03.069; PMID: 18455277
   PubMed Web of Science ®Google Scholar
• Yan J, Reichenbach DK, Corbitt N, Hokey DA, Ramanathan MP, McKinney KA, et al. Induction of antitumor immunity in vivo following delivery of a novel HPV-16 DNA vaccine encoding an E6/E7 fusion antigen. Vaccine 2009; 27:431 - 40; http://dx.doi.org/10.1016/j.vaccine.2008.10.078; PMID: 19022315
   PubMed Web of Science ®Google Scholar
• Kim D, Hoory T, Monie A, Ting JP, Hung CF, Wu TC. Enhancement of DNA vaccine potency through coadministration of CIITA DNA with DNA vaccines via gene gun. J Immunol 2008; 180:7019 - 27; PMID: 18453624
   PubMed Web of Science ®Google Scholar
• Best SR, Peng S, Juang CM, Hung CF, Hannaman D, Saunders JR, et al. Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery. Vaccine 2009; 27:5450 - 9; http://dx.doi.org/10.1016/j.vaccine.2009.07.005; PMID: 19622402
   PubMed Web of Science ®Google Scholar
• Tseng CW, Trimble C, Zeng Q, Monie A, Alvarez RD, Huh WK, et al. Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hosts. Cancer Immunol Immunother 2009; 58:737 - 48; http://dx.doi.org/10.1007/s00262-008-0596-0; PMID: 18815785
   PubMed Web of Science ®Google Scholar
• Seo SH, Jin HT, Park SH, Youn JI, Sung YC. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation. Vaccine 2009; 27:5906 - 12; http://dx.doi.org/10.1016/j.vaccine.2009.07.033; PMID: 19651174
   PubMed Web of Science ®Google Scholar
• Ohlschläger P, Quetting M, Alvarez G, Dürst M, Gissmann L, Kaufmann AM. Enhancement of immunogenicity of a therapeutic cervical cancer DNA-based vaccine by co-application of sequence-optimized genetic adjuvants. Int J Cancer 2009; 125:189 - 98; http://dx.doi.org/10.1002/ijc.24333; PMID: 19358269
   PubMed Web of Science ®Google Scholar
• Trimble CL, Peng S, Kos F, Gravitt P, Viscidi R, Sugar E, et al. A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3. Clin Cancer Res 2009; 15:361 - 7; http://dx.doi.org/10.1158/1078-0432.CCR-08-1725; PMID: 19118066
   PubMed Web of Science ®Google Scholar
• Wu A, Zeng Q, Kang TH, Peng S, Roosinovich E, Pai SI, et al. Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer. Gene Ther 2011; 18:304 - 12; http://dx.doi.org/10.1038/gt.2010.151; PMID: 20981112
   PubMed Web of Science ®Google Scholar
• Peng S, Trimble C, Alvarez RD, Huh WK, Lin Z, Monie A, et al. Cluster intradermal DNA vaccination rapidly induces E7-specific CD8+ T-cell immune responses leading to therapeutic antitumor effects. Gene Ther 2008; 15:1156 - 66; http://dx.doi.org/10.1038/gt.2008.53; PMID: 18401437
   PubMed Web of Science ®Google Scholar
• Huang CF, Monie A, Weng WH, Wu T. DNA vaccines for cervical cancer. Am J Transl Res 2010; 2:75 - 87; PMID: 20182584
   PubMed Web of Science ®Google Scholar
• Morrow MP, Pankhong P, Laddy DJ, Schoenly KA, Yan J, Cisper N, et al. Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity. Blood 2009; 113:5868 - 77; http://dx.doi.org/10.1182/blood-2008-11-190520; PMID: 19304955
   PubMed Web of Science ®Google Scholar
• Morrow MP, Yan J, Pankhong P, Shedlock DJ, Lewis MG, Talbott K, et al. IL-28B/IFN-lambda 3 drives granzyme B loading and significantly increases CTL killing activity in macaques. Mol Ther 2010; 18:1714 - 23; http://dx.doi.org/10.1038/mt.2010.118; PMID: 20571540
   PubMed Web of Science ®Google Scholar
• Bonnez W. Papilloma Virus.In: Richman D, Whitley R, Hayden F, eds. Clinical Virology. 2nd ed. Washington DC: American Society for Microbiology Press, 2002:557-96.
   Google Scholar
• Peng S, Best SR, Hung CF, Loyo M, Lyford-Pike S, Flint PW, et al. Characterization of human papillomavirus type 11-specific immune responses in a preclinical model. Laryngoscope 2010; 120:504 - 10; http://dx.doi.org/10.1002/lary.20745; PMID: 20025042
   PubMed Web of Science ®Google Scholar
• Jeong WJ, Park SW, Shin M, Lee YJ, Jeon YK, Jung YH, et al. Presence of HPV type 6 in dysplasia and carcinoma arising from recurrent respiratory papillomatosis. Head Neck 2009; 31:1095 - 101; http://dx.doi.org/10.1002/hed.20998; PMID: 19072996
   PubMed Web of Science ®Google Scholar